Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction? - sprookjes - yvandenbroek - TriplyDB

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

http://www.wikidata.org/entity/Q55365723

about

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

http://www.wikidata.org/entity/Q55365723

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@en

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@nl

type

label

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@en

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@nl

prefLabel

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@en

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@nl

P1433

Q55365723-39295F7E-AAA2-40BE-A414-A4B9F7B913B9

P1476

Q55365723-4CEAC196-61DC-4957-BF93-65C47CB81B96

P2093

Q55365723-41129E5F-AF3D-4123-97D8-0CEA8A6EF087

P2860

Q55365723-0CA454CD-6E3A-4C1E-9DB2-6C1EFB1F43EA

Q55365723-0E2EFE0C-C96C-42BE-9C83-FC6792AE7769

Q55365723-12025FDD-2B69-43F4-B9E6-62ADD0ABE9B9

Q55365723-1C005C2A-5338-40E6-B1A1-3585833E2CEF

Q55365723-25E226F6-6463-4D87-AB83-734912314129

Q55365723-33F56DE9-999D-442A-8E80-9A017CF6211D

Q55365723-3D9CF870-43F1-4D19-8D5E-7301C14705B7

Q55365723-44D3074F-5779-4D25-A4D9-50F19A5D1E43

Q55365723-47F3EB8F-61D7-4FFB-B41B-604DC29A4046

Q55365723-64B0A368-3E87-493D-820C-01F277A2411D

P304

Q55365723-60B8F4EB-6B16-43A5-A24F-10A8CD13C805

P31

Q55365723-8661374b-067b-4871-a998-9109dc461913

Q55365723-FCAD5CB3-E8EA-4D7D-8642-79BD92D89567

P356

Q55365723-E4521B8C-EBE8-4AB3-8EEC-6EBEC72A72C1

P433

Q55365723-8D645DAF-593B-43A6-8A12-2806B04E70CC

P478

Q55365723-9C82FC37-29A9-42CF-8E14-9349D06BC6D0

P50

Q55365723-46B69C87-5C91-442F-9F62-34DB4515CCC9

P577

Q55365723-24B2D3F2-20A0-4D7F-9D23-FFF70B41F2DC

P698

Q55365723-4A9A57D9-3AC4-4703-84C3-6C856C7E85E7

P921

Q55365723-DD866B86-8572-4869-8CB0-EBEB8ED6B13B

P932

Q55365723-2CF794FC-7465-42A4-9EB8-7D4B07263AD8

P356

JTD.2017.12.100

P1433

Journal of thoracic disease

P1476

Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?

@en

P2093

Caroline Ong

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes

Bivalirudin for patients with acute coronary syndromes

Bivalirudin during primary PCI in acute myocardial infarction

Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry

Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.

P304

70-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.12.100

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Sripal Bangalore

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29600024

http://www.w3.org/2001/XMLSchema#string

P921

P932

5863208

http://www.w3.org/2001/XMLSchema#string